Guinea plans to drastically reduce the number of drug importers to four
Guinean media Guineematin.com recently reported that the Guinean government plans to reduce the number of drug importers by a large margin, with the ultimate goal of reducing the number to four. Dr. Kerry, Secretary-General of Guinean Pharmacists'Union, said that 104 enterprises in Guinea had qualifications for drug imports at first and then reduced to 58. Currently, several governments plan to reduce the number of drug importers to four at a time, reaching the average level in West Africa. According to the report, four pharmaceutical importers include a state-owned enterprise in Guinea (i.e., La Pharmacie Centrale de Guinbee, the central pharmacy of Guinea), and three private enterprises.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
TB500 Peptide CAS 885340-08-9 thymosin TB 500 2mg5mg 10mg TB500 885340-08-9 peptide TDS
$60-78/UNIT FOB
2026-06-03
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
China's State Power Investment Corporation will build the largest alumina processing plant in Guinea in 2025
-
Roche Acquires Carmot for $3.1 Billion to Enter Obesity Drug Market
-
It is expected that the export volume of domestic paste resin is still difficult to improve greatly
-
Pesticide import and export situation in China in August 2022
-
Two departments issued a document to guidethe strengthening of drug cases investigation and handling
-
National Health Care Commission: 50% of thecountry's public hospitals above the second level have carried out appointmentdiagnosis and treatment services
-
India starts testing a pharmaceuticalcompany's exports of cough syrup
-
Inmanar Announces Several BreakthroughSequencing Innovations
-
China's medical supplies supply securitycapabilities continue to enhance
Recommend Reading
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
Caustic Soda Prices Weak This Week (Nov. 24–Nov. 27)
-
Shiseido's Strategic Overhaul Yields Profit Growth Amid Sales Decline
-
Clariant SynDane Catalyst Performs Excellently at Wanhua Maleic Anhydride Plant
-
MTBE Market Prices Surge and Then Fall
-
November urea market trends fluctuate and rise in China